Illumina ordered to pay Chinese language corporate $333 million in gene-sequencing patent case

Posted on 23 views

A brand new workplace construction housing genetic analysis corporate Illumina is proven in San Diego, California, U.S., Would possibly 30, 2018. REUTERS/Mike Blake

Sign in now for FREE limitless get entry to to Reuters.com

Would possibly 6 (Reuters) – A Delaware jury on Friday ordered Illumina Inc (ILMN.O) to pay greater than $333 million to a U.S. unit of Chinese language genetic research corporate BGI Genomics (300676.SZ) after discovering that Illumina’s DNA-sequencing techniques infringed two patents.

The jury additionally stated Illumina infringed the patents willfully, and that 3 patents it had accused BGI’s Entire Genomics unit of infringing had been invalid.

BGI and Illumina had been embroiled in a world felony struggle over their respective sequencing applied sciences.

Sign in now for FREE limitless get entry to to Reuters.com

Illumina in the past received $8 million from BGI in a jury verdict in San Franciscoand a ban on U.S. gross sales of a few BGI merchandise.

Within the Delaware case, San Jose, California-based Entire Genomics Inc, a BGI subsidiary, had challenged Illumina’s “two-channel” sequencing techniques and kits to arrange DNA fragments for sequencing of violating its patent rights.

An Illumina spokesperson stated the corporate plans to attraction and that the decision will have to no longer impact its talent to provide its shoppers.

An lawyer for CGI stated the corporate used to be happy with the decision.

Sign in now for FREE limitless get entry to to Reuters.com

Reporting through Blake Brittain in Washington; Modifying through David Gregorio

Our Requirements: The Thomson Reuters Accept as true with Rules.

Leave a Reply

Your email address will not be published.